Cash Homebuyers Beware: The Anti-Money Laundering Feds Are Watching You
Cash sales of residential property were on the increase, and regulators warn that money laundering through real estate can hurt home prices.
Bill Ackman Breaks Wall Street Barriers, Launches Pershing Square Fund For Retail Investors
Bill Ackman launches Pershing Square USA, making his renowned hedge fund strategies accessible to retail investors with no minimum investment.
Analysts Boost Eli Lilly’s Forecast With High Hopes On Mounjaro, Zepbound Performance
Eli Lilly's SYNERGY-NASH Phase 2 study results and positive market outlook drive BMO's raised price target to $865. Morgan Stanley remains bullish on Mounjaro/Zepbound launch. BofA Securities cites growth potential.
Investors’ Focus Around Amgen’s Obesity Drug Data Shadows Better Than Expected Q4 Earnings
Amgen's Q4 2023: 15% net profit growth, $8.2 billion total revenues beat expectations. Prolia leads with 12% sales jump. Analysts' reactions and price targets.
Aptiv’s Growth Trajectory Hits Speed Bump: Morgan Stanley Lowers Forecast
Aptiv shares decline as Morgan Stanley downgrades to Underweight, citing concerns over Q4 FY23 results and a lowered price target of $74. Analyst Adam Jonas warns of EV demand slowdown, impacting Aptiv's growth outlook.
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What’s Driving Markets Wednesday?
Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments such as regional banks, highlighting investor caution.
Brookfield Asset Management Posts Mixed Q4 But Says $107B Dry Powder Promises Busy Dealmaking Year
Brookfield Asset Management Ltd (NYSE: BAM) reports mixed Q4 results, with revenue surpassing estimates at $1.13 billion but EPS falling short at $0.23, missing consensus. Despite this, distributable earnings climb to $586 million, highlighting strong fundraising and capital deployment efforts.
Used Car Blues Hit Bottom Line, But Penske Speeds Ahead with Sales Growth
Penske Automotive Group Q4 FY23 performance, boasting $7.27 billion in sales, surpassing analyst projections. Despite hurdles in the used vehicle market, PAG delivers notable growth, including an 8% surge in retail automotive new units and a 7% rise in same-store service and parts gross profit.
Why Electronic Equipment Company CDW Shares Are Up Today
CDW experiences stock surge post-Q4 FY23 results, though net sales dip to $5.02 billion, missing estimates. However, the company boasts an expanded gross margin of 23.0% and beats consensus with non-GAAP EPS of $2.57. CEO Christine A. Leahy expresses confidence in the company's trajectory, aiming to outpace US IT market growth by 200 to 300 basis points in 2024. Despite segment declines, CDW remains committed to customer-centric strategies and technology evolution.
CVS Health’s Q4 Earnings Relieve Investor Concerns But Lowers 2024 Profit Guidance Citing Elevated Medical Cost Trends
CVS Health beats Q4 expectations with $2.12 adjusted EPS, allays concerns over healthcare costs. Sales rise 11.9% to $93.81 billion.